Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mechanics | 13 | 2006 | 77 | 1.030 |
Why?
|
| Lung | 9 | 2011 | 1555 | 0.710 |
Why?
|
| Airway Resistance | 12 | 2011 | 37 | 0.660 |
Why?
|
| Muscle, Smooth | 3 | 2011 | 138 | 0.550 |
Why?
|
| Muscle Contraction | 3 | 2011 | 197 | 0.410 |
Why?
|
| Asthma | 7 | 2007 | 810 | 0.380 |
Why?
|
| Positive-Pressure Respiration | 4 | 2005 | 85 | 0.350 |
Why?
|
| Actins | 1 | 2011 | 352 | 0.320 |
Why?
|
| Bronchoconstriction | 3 | 2006 | 18 | 0.300 |
Why?
|
| Methacholine Chloride | 5 | 2011 | 22 | 0.280 |
Why?
|
| Desmin | 1 | 2005 | 21 | 0.250 |
Why?
|
| Thorax | 2 | 1994 | 73 | 0.200 |
Why?
|
| Lung Compliance | 6 | 2005 | 20 | 0.190 |
Why?
|
| Bronchi | 2 | 2001 | 108 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2007 | 253 | 0.170 |
Why?
|
| Bronchial Provocation Tests | 4 | 2007 | 15 | 0.170 |
Why?
|
| Crying | 2 | 1991 | 12 | 0.170 |
Why?
|
| Respiratory System | 2 | 2006 | 100 | 0.170 |
Why?
|
| Pulmonary Ventilation | 3 | 2006 | 29 | 0.160 |
Why?
|
| Interleukin-5 | 1 | 1999 | 48 | 0.160 |
Why?
|
| Lung Volume Measurements | 6 | 2001 | 77 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2018 | 149 | 0.140 |
Why?
|
| Elasticity | 5 | 2005 | 94 | 0.140 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 90 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2018 | 243 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2004 | 157 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 6 | 2007 | 1079 | 0.120 |
Why?
|
| Animals | 21 | 2011 | 36364 | 0.120 |
Why?
|
| Respiration, Artificial | 4 | 2011 | 497 | 0.120 |
Why?
|
| Ovalbumin | 4 | 2007 | 321 | 0.120 |
Why?
|
| Respiratory Muscles | 2 | 1991 | 8 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 1069 | 0.100 |
Why?
|
| Airway Obstruction | 2 | 2006 | 168 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2011 | 3968 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 1022 | 0.100 |
Why?
|
| Pulmonary Alveoli | 4 | 2001 | 142 | 0.100 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2004 | 94 | 0.100 |
Why?
|
| Mice | 10 | 2011 | 18876 | 0.100 |
Why?
|
| Smooth Muscle Myosins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2011 | 18 | 0.100 |
Why?
|
| Vagotomy | 1 | 1991 | 10 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 4799 | 0.090 |
Why?
|
| Aging | 2 | 2001 | 1304 | 0.090 |
Why?
|
| Posture | 1 | 1992 | 157 | 0.090 |
Why?
|
| Nadolol | 2 | 2007 | 29 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 173 | 0.090 |
Why?
|
| Neuromuscular Diseases | 1 | 1991 | 57 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 290 | 0.080 |
Why?
|
| Status Asthmaticus | 1 | 1989 | 20 | 0.080 |
Why?
|
| Muscle Proteins | 1 | 2011 | 424 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2001 | 38 | 0.070 |
Why?
|
| Dogs | 5 | 2001 | 800 | 0.070 |
Why?
|
| Propanolamines | 1 | 2007 | 33 | 0.070 |
Why?
|
| Metoprolol | 1 | 2007 | 22 | 0.070 |
Why?
|
| Bronchoconstrictor Agents | 2 | 2006 | 11 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2007 | 90 | 0.070 |
Why?
|
| Models, Biological | 6 | 1994 | 1535 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 321 | 0.060 |
Why?
|
| Cats | 4 | 1994 | 126 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2900 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2001 | 830 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 1054 | 0.060 |
Why?
|
| Air Pressure | 2 | 1994 | 4 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 590 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 65 | 0.050 |
Why?
|
| CD18 Antigens | 1 | 2003 | 56 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 1986 | 264 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2003 | 63 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 83 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 1735 | 0.050 |
Why?
|
| Viscosity | 3 | 1991 | 43 | 0.050 |
Why?
|
| Administration, Intranasal | 2 | 2000 | 138 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 1984 | 154 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 215 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 451 | 0.050 |
Why?
|
| Body Weight | 2 | 2001 | 1034 | 0.050 |
Why?
|
| Macrophage-1 Antigen | 1 | 2001 | 33 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2005 | 349 | 0.050 |
Why?
|
| Parasympathetic Nervous System | 1 | 2001 | 15 | 0.050 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2000 | 8 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2001 | 54 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2001 | 109 | 0.040 |
Why?
|
| Male | 12 | 2007 | 65830 | 0.040 |
Why?
|
| Pneumonia, Aspiration | 1 | 2000 | 18 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 473 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2000 | 98 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2001 | 106 | 0.040 |
Why?
|
| Organ Size | 1 | 2001 | 468 | 0.040 |
Why?
|
| Milk | 1 | 2000 | 126 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 1999 | 13 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2001 | 991 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 75 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2018 | 37 | 0.040 |
Why?
|
| Haemophilus Infections | 1 | 1979 | 95 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 66 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 1979 | 109 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1305 | 0.040 |
Why?
|
| Immunization | 1 | 1999 | 315 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 360 | 0.030 |
Why?
|
| Anthropometry | 2 | 1989 | 202 | 0.030 |
Why?
|
| Female | 10 | 2007 | 71587 | 0.030 |
Why?
|
| Pneumococcal Infections | 1 | 1979 | 276 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 382 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1979 | 325 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 711 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1695 | 0.030 |
Why?
|
| Plethysmography | 1 | 1994 | 36 | 0.030 |
Why?
|
| Rats | 1 | 2001 | 3878 | 0.030 |
Why?
|
| Child, Preschool | 5 | 1991 | 14787 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 1993 | 43 | 0.030 |
Why?
|
| Algorithms | 1 | 2001 | 1728 | 0.030 |
Why?
|
| Histamine | 1 | 1993 | 49 | 0.030 |
Why?
|
| Anesthesia | 2 | 1993 | 213 | 0.030 |
Why?
|
| Pressure | 2 | 1990 | 138 | 0.030 |
Why?
|
| Humans | 12 | 2018 | 133809 | 0.030 |
Why?
|
| Rabbits | 1 | 1993 | 736 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 4769 | 0.020 |
Why?
|
| Supine Position | 1 | 1992 | 26 | 0.020 |
Why?
|
| Infant | 4 | 1991 | 13148 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1990 | 33 | 0.020 |
Why?
|
| Bronchospirometry | 1 | 1989 | 1 | 0.020 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1989 | 5 | 0.020 |
Why?
|
| Inspiratory Reserve Volume | 1 | 1989 | 1 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 225 | 0.020 |
Why?
|
| Esophagus | 1 | 1991 | 233 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1991 | 328 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1989 | 174 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3476 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 212 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 433 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 9 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2006 | 41 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 754 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2005 | 113 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 1136 | 0.010 |
Why?
|
| Sex Factors | 1 | 1989 | 1384 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1986 | 221 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2005 | 17457 | 0.010 |
Why?
|
| Adolescent | 3 | 2005 | 20542 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1989 | 1255 | 0.010 |
Why?
|
| Body Mass Index | 1 | 1991 | 1708 | 0.010 |
Why?
|
| Radiography | 1 | 1986 | 825 | 0.010 |
Why?
|
| Leishmania major | 1 | 2003 | 29 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2006 | 198 | 0.010 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2003 | 49 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2003 | 147 | 0.010 |
Why?
|
| Adult | 3 | 2007 | 31928 | 0.010 |
Why?
|
| Time Factors | 2 | 1990 | 6584 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 1488 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 572 | 0.010 |
Why?
|
| Age Factors | 1 | 1989 | 2978 | 0.010 |
Why?
|
| Antigens | 1 | 2001 | 157 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2000 | 7 | 0.010 |
Why?
|
| Child | 3 | 1989 | 25743 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2157 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2000 | 203 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 588 | 0.010 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1979 | 4 | 0.010 |
Why?
|
| Models, Animal | 1 | 2000 | 483 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1986 | 911 | 0.010 |
Why?
|
| Haemophilus influenzae | 1 | 1979 | 134 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1979 | 320 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 6660 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 5175 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5503 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 1595 | 0.010 |
Why?
|
| Bacteria | 1 | 1979 | 537 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 4893 | 0.010 |
Why?
|
| Oscillometry | 1 | 1990 | 15 | 0.010 |
Why?
|
| Gases | 1 | 1990 | 20 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1990 | 14 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1989 | 7 | 0.010 |
Why?
|
| Respiration | 1 | 1989 | 125 | 0.000 |
Why?
|
| Reference Values | 1 | 1989 | 744 | 0.000 |
Why?
|
| Forecasting | 1 | 1989 | 376 | 0.000 |
Why?
|
| Middle Aged | 1 | 2007 | 29350 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1990 | 8582 | 0.000 |
Why?
|